Alberts M, Zhdanava M, Pilon D, Caron-Lapointe G, Lefebvre P, Bookhart B
Adv Ther. 2023; 40(4):1750-1764.
PMID: 36823479
PMC: 10070307.
DOI: 10.1007/s12325-022-02391-z.
Martsevich S, Lukina Y, Kutishenko N, Kiselev A, Drapkina O
Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297321
PMC: 9610593.
DOI: 10.3390/ph15101209.
Polymeris A, Zietz A, Schaub F, Meya L, Traenka C, Thilemann S
Eur Stroke J. 2022; 7(3):221-229.
PMID: 36082252
PMC: 9446322.
DOI: 10.1177/23969873221099477.
Romagnoli A, Santoleri F, Costantini A, Di Risio A
Eur J Hosp Pharm. 2022; 31(2):156-161.
PMID: 35961767
PMC: 10895192.
DOI: 10.1136/ejhpharm-2022-003338.
Speed V, Auyeung V, Patel J, Cooper D, Miller S, Roberts L
Res Pract Thromb Haemost. 2021; 5(8):e12614.
PMID: 34849447
PMC: 8606029.
DOI: 10.1002/rth2.12614.
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015).
Sabate M, Vidal X, Ballarin E, Rottenkolber M, Schmiedl S, Grave B
Front Pharmacol. 2021; 12:682890.
PMID: 34803665
PMC: 8596153.
DOI: 10.3389/fphar.2021.682890.
Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation.
An J, Bider Z, Luong T, Cheetham T, Lang D, Fischer H
J Am Heart Assoc. 2021; 10(21):e021601.
PMID: 34713708
PMC: 8751846.
DOI: 10.1161/JAHA.121.021601.
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Zielinski G, van Rein N, Teichert M, Klok F, Rosendaal F, van der Meer F
Pharmacoepidemiol Drug Saf. 2021; 30(8):1027-1036.
PMID: 33822401
PMC: 8360064.
DOI: 10.1002/pds.5242.
Engaging Patients in Atrial Fibrillation Management via Digital Health Technology: The Impact of Tailored Messaging.
Toscos T, Coupe A, Wagner S, Ahmed R, Roebuck A, Flanagan M
J Innov Card Rhythm Manag. 2020; 11(8):4209-4217.
PMID: 32874747
PMC: 7452738.
DOI: 10.19102/icrm.2020.110802.
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.
Paquette M, Mbuagbaw L, Iorio A, Nieuwlaat R
Eur Heart J Cardiovasc Pharmacother. 2020; 7(3):251-260.
PMID: 32428195
PMC: 8141301.
DOI: 10.1093/ehjcvp/pvaa052.
Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases.
Cho I
Ther Clin Risk Manag. 2019; 15:1183-1206.
PMID: 31632045
PMC: 6790210.
DOI: 10.2147/TCRM.S204377.
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey.
Lane D, Meyerhoff J, Rohner U, Lip G
TH Open. 2019; 2(3):e233-e241.
PMID: 31249947
PMC: 6524879.
DOI: 10.1055/s-0038-1666803.
Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.
Rodriguez-Bernal C, Garcia-Sempere A, Hurtado I, Santa-Ana Y, Peiro S, Sanfelix-Gimeno G
BMJ Open. 2018; 8(12):e025102.
PMID: 30573490
PMC: 6303591.
DOI: 10.1136/bmjopen-2018-025102.
Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain.
Hurtado-Navarro I, Garcia-Sempere A, Rodriguez-Bernal C, Santa-Ana-Tellez Y, Peiro S, Sanfelix-Gimeno G
Front Pharmacol. 2018; 9:1353.
PMID: 30559661
PMC: 6287024.
DOI: 10.3389/fphar.2018.01353.
Direct oral anticoagulants: a review of common medication errors.
Barr D, Epps Q
J Thromb Thrombolysis. 2018; 47(1):146-154.
PMID: 30298305
DOI: 10.1007/s11239-018-1752-9.
Dabigatran persistence and adherence in New Zealand: a nationwide retrospective observational study.
Harper P, Pollock D, Stephens M
BMJ Open. 2018; 8(4):e020212.
PMID: 29626048
PMC: 5892768.
DOI: 10.1136/bmjopen-2017-020212.
Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
McHorney C, Crivera C, Laliberte F, Germain G, Wynant W, Lefebvre P
PLoS One. 2018; 13(4):e0194099.
PMID: 29621248
PMC: 5886396.
DOI: 10.1371/journal.pone.0194099.
Evaluating the Usability and Usefulness of a Mobile App for Atrial Fibrillation Using Qualitative Methods: Exploratory Pilot Study.
Hirschey J, Bane S, Mansour M, Sperber J, Agboola S, Kvedar J
JMIR Hum Factors. 2018; 5(1):e13.
PMID: 29549073
PMC: 5876493.
DOI: 10.2196/humanfactors.8004.
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
Eek A, Oie E, Granas A
Eur J Clin Pharmacol. 2017; 74(3):323-330.
PMID: 29149366
DOI: 10.1007/s00228-017-2374-4.
Patients' knowledge on oral anticoagulant treatment in Hungary.
Viola R, Fekete H, Csoka I
Int J Clin Pharm. 2017; 39(6):1265-1272.
PMID: 29052116
DOI: 10.1007/s11096-017-0544-1.
